Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.31 (
beta-glucuronidase
)
7,680
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The binding of five barley proteins (Mr: 37, 36, 35, 34, and 30 kDa) to the
ICR2
motif present at the 5' end of brome mosaic virus (BMV) RNA-2 was identified using UV cross-linking. Evidence that the interaction is specific included the observation that these proteins did not recognize a similar-size RNA fragment transcribed from a nonviral (
beta-glucuronidase
) gene, nor did they bind to the 3' end of the plus strand of RNA-3. Replication-defective BMV RNA-2 mutants bearing substitution mutations at nucleotides 9 and 10 of the
ICR2
motif were used to show that these positions were involved in the interaction of the five barley proteins with BMV RNA-2. Surprisingly, the profile of barley proteins interacting with the 3' end of the minus strand of RNA-2 was similar to that seen for the 5' end of the plus strand. Further, the profile of proteins binding to minus-sense probes bearing substitution mutations in the
ICR2
region differed from that found for the wild-type sequence. These findings support the concept that host proteins are involved in genome replication and that their ability to interact with both plus and minus strands of the viral RNA is probably involved with the initiation of plus-strand synthesis.
...
PMID:Interaction of host proteins with the plus-strand promoter of brome mosaic virus RNA-2. 855 68